000 01332 a2200325 4500
005 20250516091655.0
264 0 _c20121018
008 201210s 0 0 eng d
022 _a1532-2084
024 7 _a10.1016/j.drup.2012.04.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKleibeuker, Esther A
245 0 0 _aCombining angiogenesis inhibition and radiotherapy: a double-edged sword.
_h[electronic resource]
260 _bDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
_cJun 2012
300 _a173-82 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xblood supply
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
700 1 _aGriffioen, Arjan W
700 1 _aVerheul, Henk M
700 1 _aSlotman, Ben J
700 1 _aThijssen, Victor L
773 0 _tDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
_gvol. 15
_gno. 3
_gp. 173-82
856 4 0 _uhttps://doi.org/10.1016/j.drup.2012.04.002
_zAvailable from publisher's website
999 _c21758258
_d21758258